CU6 clarity pharmaceuticals ltd

Ann: Last patient assessment completed for SARTATE trial, page-26

  1. 155 Posts.
    lightbulb Created with Sketch. 207
    So how did we get from, "It won't matter too much by the time this gets to market because the newer scanners..." (basically saying that there won't be a use for this product because the newer scanners will be at market) to "It's certainly not going to be a winner takes all type scenario.It's much more nuanced than that and there's space for everyone to play."?

    The two statements seem a bit contradictory no?

    And also...this is a thread on a diagnostic product for NETs - is there anyone running a trial using one of the newer scanners and an NET diagnostic agent?


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$4.37
Change
0.040(0.92%)
Mkt cap ! $1.413B
Open High Low Value Volume
$4.41 $4.57 $4.32 $15.13M 3.417M

Buyers (Bids)

No. Vol. Price($)
2 8635 $4.37
 

Sellers (Offers)

Price($) Vol. No.
$4.41 24128 2
View Market Depth
Last trade - 16.10pm 31/07/2025 (20 minute delay) ?
CU6 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.